176 related articles for article (PubMed ID: 30655611)
1. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation.
Jeong WJ; Park JC; Kim WS; Ro EJ; Jeon SH; Lee SK; Park YN; Min DS; Choi KY
Nat Commun; 2019 Jan; 10(1):295. PubMed ID: 30655611
[TBL] [Abstract][Full Text] [Related]
2. WDR76 degrades RAS and suppresses cancer stem cell activation in colorectal cancer.
Ro EJ; Cho YH; Jeong WJ; Park JC; Min DS; Choi KY
Cell Commun Signal; 2019 Jul; 17(1):88. PubMed ID: 31362761
[TBL] [Abstract][Full Text] [Related]
3. WDR76 mediates obesity and hepatic steatosis via HRas destabilization.
Park JC; Jeong WJ; Seo SH; Choi KY
Sci Rep; 2019 Dec; 9(1):19676. PubMed ID: 31873167
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
6. Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.
Xu A; Wang B; Fu J; Qin W; Yu T; Yang Z; Lu Q; Chen J; Chen Y; Wang H
Cancer Lett; 2019 Feb; 442():40-52. PubMed ID: 30401637
[TBL] [Abstract][Full Text] [Related]
7. Comparison of liver oncogenic potential among human RAS isoforms.
Chung SI; Moon H; Ju HL; Kim DY; Cho KJ; Ribback S; Dombrowski F; Calvisi DF; Ro SW
Oncotarget; 2016 Feb; 7(6):7354-66. PubMed ID: 26799184
[TBL] [Abstract][Full Text] [Related]
8. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
[TBL] [Abstract][Full Text] [Related]
9. The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.
Sheppard S; Guedes J; Mroz A; Zavitsanou AM; Kudo H; Rothery SM; Angelopoulos P; Goldin R; Guerra N
Nat Commun; 2017 Jan; 8():13930. PubMed ID: 28128200
[TBL] [Abstract][Full Text] [Related]
10. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.
Li K; Zheng X; Tang H; Zang YS; Zeng C; Liu X; Shen Y; Pang Y; Wang S; Xie F; Lu X; Luo Y; Li Z; Bi W; Jia X; Huang T; Wei R; Huang K; Chen Z; Zhu Q; He Y; Zhang M; Gu Z; Xiao Y; Zhang X; Fletcher JA; Wang Y
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34143182
[TBL] [Abstract][Full Text] [Related]
11. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
13. New Concept of Hepatocellular Carcinoma Treatment with the Tumor Suppressor 'WDR76' through 'RAS' Degradation.
Park JY
Korean J Gastroenterol; 2019 Mar; 73(3):190-191. PubMed ID: 31013564
[No Abstract] [Full Text] [Related]
14. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
15. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
17. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S
Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.
Kwon T; Bak Y; Park YH; Jang GB; Nam JS; Yoo JE; Park YN; Bak IS; Kim JM; Yoon DY; Yu DY
Stem Cells; 2016 May; 34(5):1188-97. PubMed ID: 26866938
[TBL] [Abstract][Full Text] [Related]
20. ras oncogene p21 expression in hepatocellular carcinoma.
Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
